TCR alpha/beta and CD19-depleted haploidentical HSCT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TCR alpha/beta and CD19-depleted haploidentical HSCT, covering 2024-10-18 to 2024-10-18. Get the full timeline:
Most recent: Clinical Trial Update: TCR Alpha/Beta and CD19-deplete Haplo-HSCT [Phase 2]